GMED vs WST
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Feb 02, 2026
GMED
56.4
AI Score
VS
It's a Tie!
WST
56.4
AI Score
Investment Advisor Scores
WST
56score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | GMED | WST | Winner |
|---|---|---|---|
| Revenue | 2.11B | 2.27B | WST |
| Net Income | 397.27M | 361.60M | GMED |
| Net Margin | 18.8% | 15.9% | GMED |
| Operating Income | 310.48M | 428.30M | WST |
| ROE | 9.0% | 11.8% | WST |
| ROA | 7.8% | 8.8% | WST |
| Total Assets | 5.10B | 4.11B | GMED |
| Current Ratio | 4.13 | 2.87 | GMED |
| Free Cash Flow | 386.38M | 293.90M | GMED |
Frequently Asked Questions
Based on our detailed analysis, GMED and WST are evenly matched, both winning 5 key financial metrics each. This is a close call that depends on your specific investment goals.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.